Conclusion In-tensive atorvastatin therapy increases the rate of reaching the lipoprotein regulating goal of ACS patients, and continually reduces Us-CRP, and controls plaque inflammation.

结论阿托伐他汀长期治疗ACS能提高患者降脂达标率，持续降低患者血清超敏CRP，抑制斑块内炎症反应。

youdao

Conclusion In-tensive atorvastatin therapy increases the rate of reaching the lipoprotein regulating goal of ACS patients, and continually reduces Us-CRP, and controls plaque inflammation.

结论阿托伐他汀长期治疗ACS能提高患者降脂达标率，持续降低患者血清超敏CRP，抑制斑块内炎症反应。

youdao